Actionable news
All posts from Actionable news
Actionable news in CELG: Celgene Corporation,

Which Pipeline Has Better Potential: Celgene or Biogen?

Celgene Corp. (NASDAQ:CELG) and Biogen Inc. (NASDAQ:BIIB) are both biotech industry titans, but for investors who can only add one of these two stocks to their portfolio, which is the better buy? Although Biogen has an intriguing Alzheimer's disease moonshot advancing through R&D, various potential blockbusters lurking in Celgene's pipeline are closer to commercialization.

In this clip from The Motley Fool's Industry Focus: Healthcare podcast, analyst Kristine Harjes and healthcare contributor Todd Campbell compare the two drugmakers' pipeline potential to explain which of these two Goliaths they would choose.

A transcript follows the video.

Is Celgene the next stock to buy?
This Friday, Motley Fool co-founders David and Tom Gardner will reveal their newest stock picks -- will Celgene be their next big winner? Together, these brothers have tripled the stock market's return in Motley Fool Stock Advisor over the last 13 years, and it hasn't been through blind luck...

Click here to learn how you can get David and Tom's newest stock recommendations.

This podcast was recorded on Jul. 1, 2016.

Kristine Harjes: With Biogen, as we've mentioned on the show a few times...